318 related articles for article (PubMed ID: 3571935)
41. Relative versus absolute carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with acute alcoholic hepatitis.
Halm U; Tannapfel A; Mössner J; Berr F
Alcohol Clin Exp Res; 1999 Oct; 23(10):1614-8. PubMed ID: 10549992
[TBL] [Abstract][Full Text] [Related]
42. Hyposplenism in alcoholic cirrhosis, facts or artifacts? A comparative analysis with non-alcoholic cirrhosis and extrahepatic portal venous obstruction.
Satapathy SK; Narayan S; Varma N; Dhiman RK; Varma S; Chawla Y
J Gastroenterol Hepatol; 2001 Sep; 16(9):1038-43. PubMed ID: 11595070
[TBL] [Abstract][Full Text] [Related]
43. Circulating lipocalin 2 is neither related to liver steatosis in patients with non-alcoholic fatty liver disease nor to residual liver function in cirrhosis.
Meier EM; Pohl R; Rein-Fischboeck L; Schacherer D; Eisinger K; Wiest R; Krautbauer S; Buechler C
Cytokine; 2016 Sep; 85():45-50. PubMed ID: 27288631
[TBL] [Abstract][Full Text] [Related]
44. Survival in hepatitis-B cirrhosis compared to alcoholic cirrhosis in patients with Child's C liver disease: a prospective study of endoscopic sclerotherapy for bleeding oesophageal varices.
Lee SM; Wong NW
Singapore Med J; 1994 Feb; 35(1):53-6. PubMed ID: 8009280
[TBL] [Abstract][Full Text] [Related]
45. Presence of plasma endotoxin is correlated with tumour necrosis factor receptor levels and disease activity in alcoholic cirrhosis.
Hanck C; Rossol S; Böcker U; Tokus M; Singer MV
Alcohol Alcohol; 1998; 33(6):606-8. PubMed ID: 9872348
[TBL] [Abstract][Full Text] [Related]
46. [Bacterial endotoxinemia and risk of hemorrhage from oesophageal varicose veins in patients with liver cirrhosis].
Garbuzenko DV; Mikurov AA; Smirnov DM
Klin Med (Mosk); 2012; 90(7):48-51. PubMed ID: 23019976
[TBL] [Abstract][Full Text] [Related]
47. [Alcoholic fatty liver, alcoholic hepatitis and alcoholic cirrhosis. Drinking behavior and incidence of clinical, clinico-chemical and histological findings in 282 patients].
Bode JC; Kruse G; Mexas P; Martini GA
Dtsch Med Wochenschr; 1984 Oct; 109(40):1516-21. PubMed ID: 6236965
[TBL] [Abstract][Full Text] [Related]
48. Total fasting serum bile acids and beta-hexosaminidase in alcoholic liver disease.
Joelsson B; Hultberg B; Isaksson A; Alwmark A; Gullstrand P; Bengmark S
Clin Chim Acta; 1984 Jan; 136(2-3):203-9. PubMed ID: 6229367
[TBL] [Abstract][Full Text] [Related]
49. [Complications of hepatic coma in liver cirrhosis].
Grüngreiff K
Gastroenterol J; 1990; 50(2):82-7. PubMed ID: 2222788
[TBL] [Abstract][Full Text] [Related]
50. Zinc absorption and leukocyte zinc in alcoholic and nonalcoholic cirrhosis.
Valberg LS; Flanagan PR; Ghent CN; Chamberlain MJ
Dig Dis Sci; 1985 Apr; 30(4):329-33. PubMed ID: 3979239
[TBL] [Abstract][Full Text] [Related]
51. Lasting nutritional imbalance following abstinence in patients with alcoholic cirrhosis.
Watanabe A; Shiota T; Okita M; Nagashima H
J Med; 1989; 20(5-6):331-6. PubMed ID: 2628516
[TBL] [Abstract][Full Text] [Related]
52. Portal and peripheral endotoxins in patients with esophageal varices undergoing surgery.
Kikuchi M; Watanabe M; Nakamura R; Endo S; Kuwata Y; Saito K; Inada K; Yoshida M
Surg Today; 1995; 25(1):17-20. PubMed ID: 7749284
[TBL] [Abstract][Full Text] [Related]
53. Endotoxemia and hyperbilirubinemia in the neonate.
Goldberg PK; Kozinn PJ; Kodsi B; Lewitis R; Ackerman B; Aschenbrand L; Feldman F
Am J Dis Child; 1982 Sep; 136(9):845-8. PubMed ID: 7114008
[TBL] [Abstract][Full Text] [Related]
54. Influence of alcohol on branched-chain amino acid/tyrosine molar ratio in patients with cirrhosis.
Suzuki H; Mamata Y; Mizuno H; Tominaga T; Suga M; Suemori S; Sato A; Suzuki M
Alcohol Clin Exp Res; 1998 May; 22(S3 Pt 1):137S-140S. PubMed ID: 9622391
[TBL] [Abstract][Full Text] [Related]
55. A study of endotoxaemia in patients with primary biliary cirrhosis.
Yamamoto Y; Sezai S; Sakurabayashi S; Hirano M; Kamisaka K; Oka H
J Int Med Res; 1994; 22(2):95-9. PubMed ID: 8020644
[TBL] [Abstract][Full Text] [Related]
56. [Endotoxemia and its compensatory mechanisms in experimental liver cirrhosis].
Ueno M
Nihon Shokakibyo Gakkai Zasshi; 1990 Aug; 87(8):1692-700. PubMed ID: 2232302
[TBL] [Abstract][Full Text] [Related]
57. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
Genesca J; Gonzalez A; Segura R; Catalan R; Marti R; Varela E; Cadelina G; Martinez M; Lopez-Talavera JC; Esteban R; Groszmann RJ; Guardia J
Am J Gastroenterol; 1999 Jan; 94(1):169-77. PubMed ID: 9934750
[TBL] [Abstract][Full Text] [Related]
58. Concentrations of lipopolysaccharide-binding protein, bactericidal/permeability-increasing protein, soluble CD14 and plasma lipids in relation to endotoxaemia in patients with alcoholic liver disease.
Schäfer C; Parlesak A; Schütt C; Bode JC; Bode C
Alcohol Alcohol; 2002; 37(1):81-6. PubMed ID: 11825862
[TBL] [Abstract][Full Text] [Related]
59. [Progress of endotoxin and chronic liver disease].
Wang L; Ren CS
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):251-3. PubMed ID: 12716536
[No Abstract] [Full Text] [Related]
60. Spontaneous regression of oesophageal varices after long-term conservative treatment. Retrospective study in 20 patients with alcoholic liver cirrhosis, posthepatitic cirrhosis and haemochromatosis with cirrhosis.
Müting D; Kalk JF; Fischer R; Wiewel D
J Hepatol; 1990 Mar; 10(2):158-62. PubMed ID: 2332585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
